Challenges to identifying risk versus protective factors in Alzheimer’s disease
- 18 July 2024
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 30 (11) , 3094-3095
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- APOE4 homozygosity represents a distinct genetic form of Alzheimer’s diseaseNature Medicine, 2024
- Cognitive resilience/reserve: Myth or reality? A review of definitions and measurement methodsAlzheimer's & Dementia, 2024
- A framework for concepts of reserve and resilience in agingNeurobiology of Aging, 2022
- Cognitive Resilience in Brain Health and Dementia ResearchJournal of Alzheimer’s Disease, 2022
- Biomarker‐based stability in limbic‐predominant amnestic mild cognitive impairmentEuropean Journal of Neurology, 2020
- Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of expertsClinical Neurophysiology, 2020
- The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer’s Disease DiagnosisJournal of Alzheimer’s Disease, 2019
- Cognitive reserve2019
- Alzheimer's disease2019
- Mild Cognitive ImpairmentContinuum, 2016